Liquidia Corp SEC filings LQDA
Liquidia Corp has 702 filings in SEC EDGAR's recent list, going back to Aug 5, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, agreement ended, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 26, 2025 | — |
| CORRESP | Letter to the SEC | Mar 21, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2025 | — |
| EFFECT | Filing | Jul 5, 2024 | — |
| CORRESP | Letter to the SEC | Jul 2, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2024 | — |
| EFFECT | Filing | Jan 3, 2024 | — |
| CORRESP | Letter to the SEC | Dec 29, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2023 | — |
| EFFECT | Filing | Sep 14, 2021 | — |
| CORRESP | Letter to the SEC | Sep 10, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2021 | — |
| D | Filing | Apr 16, 2021 | — |
| 8-K12B/A | Filing | Feb 2, 2021 | Nov 18, 2020 |
| EFFECT | Filing | Dec 23, 2020 | — |
| CORRESP | Letter to the SEC | Dec 22, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2020 | — |
| 8-K12B | Filing | Nov 18, 2020 | Nov 18, 2020 |
| 425 | Filing | Nov 16, 2020 | — |
| 425 | Filing | Nov 9, 2020 | — |
| 425 | Filing | Sep 18, 2020 | — |
| 425 | Filing | Sep 17, 2020 | — |
| EFFECT | Filing | Sep 16, 2020 | — |
| CORRESP | Letter to the SEC | Sep 14, 2020 | — |
| CORRESP | Letter to the SEC | Sep 4, 2020 | — |
| 425 | Filing | Aug 20, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2020 | — |
| 425 | Filing | Aug 10, 2020 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LQDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Morrisville, NC
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1819576
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.